Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 7284872, 14 pages
https://doi.org/10.1155/2017/7284872
Research Article

Tumorigenic and Differentiation Potentials of Embryonic Stem Cells Depend on TGFβ Family Signaling: Lessons from Teratocarcinoma Cells Stimulated to Differentiate with Retinoic Acid

1Kol’tsov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, Moscow 119334, Russia
2Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Street 16/10, Moscow 117997, Russia

Correspondence should be addressed to Olga Gordeeva; ur.xednay@aveedrogaglo

Received 7 April 2017; Revised 1 June 2017; Accepted 13 June 2017; Published 16 July 2017

Academic Editor: Tilo Kunath

Copyright © 2017 Olga Gordeeva and Sergey Khaydukov. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Martin, “Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 12, pp. 7634–7638, 1981. View at Google Scholar
  2. M. J. Evans and M. H. Kaufman, “Establishment in culture of pluripotential cells from mouse embryos,” Nature, vol. 292, no. 5819, pp. 154–156, 1981. View at Google Scholar
  3. Y. Matsui, K. Zsebo, and B. L. Hogan, “Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture,” Cell, vol. 70, no. 5, pp. 841–847, 1992. View at Google Scholar
  4. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Google Scholar
  5. M. J. Shamblott, J. Axelman, S. Wang et al., “Derivation of pluripotent stem cells from cultured human primordial germ cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13726–13731, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Google Scholar
  7. W. E. Lowry, L. Richter, R. Yachechko et al., “Generation of human induced pluripotent stem cells from dermal fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 2883–2888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Park, P. H. Lerou, R. Zhao, H. Huo, and G. Q. Daley, “Generation of human-induced pluripotent stem cells,” Nature Protocols, vol. 3, no. 7, pp. 1180–1186, 2008. View at Google Scholar
  9. M. Tachibana, P. Amato, M. Sparman et al., “Human embryonic stem cells derived by somatic cell nuclear transfer,” Cell, vol. 153, no. 6, pp. 1228–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Nagy, E. Gócza, E. M. Diaz et al., “Embryonic stem cells alone are able to support fetal development in the mouse,” Development (Cambridge, England), vol. 110, no. 3, pp. 815–821, 1990. View at Google Scholar
  11. A. Nagy, J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder, “Derivation of completely cell culture-derived mice from early-passage embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8424–8428, 1993. View at Google Scholar
  12. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at Google Scholar
  13. I. Polejaeva and S. Mitalipov, “Stem cell potency and the ability to contribute to chimeric organisms,” Reproduction (Cambridge, England), vol. 145, no. 3, pp. R81–R88, 2013. View at Google Scholar
  14. S. A. Przyborski, “Differentiation of human embryonic stem cells after transplantation in immune-deficient mice,” Stem Cells, vol. 23, no. 9, pp. 1242–1250, 2005. View at Google Scholar
  15. M. Drukker, H. Katchman, G. Katz et al., “Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells,” Stem Cells, vol. 24, no. 2, pp. 221–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Brederlau, A. S. Correia, S. V. Anisimov et al., “Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson’s disease: effect of in vitro differentiation on graft survival and teratoma formation,” Stem Cells, vol. 24, no. 6, pp. 1433–1440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Dressel, J. Schindehütte, T. Kuhlmann et al., “The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients’ immune response,” PLoS One, vol. 3, no. 7, article e2622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Dressel, “Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells,” Seminars in Immunopathology, vol. 33, no. 6, pp. 573–591, 2011. View at Google Scholar
  19. R. Swijnenburg, S. Schrepfer, J. A. Govaert et al., “Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 12991–12996, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sundberg, P. Andersson, E. Åkesson et al., “Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue,” Cell Transplantation, vol. 20, no. 2, pp. 177–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. O. F. Gordeeva and T. M. Nikonova, “Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice,” Cell Transplantation, vol. 22, no. 10, pp. 1901–1914, 2013. View at Google Scholar
  22. B. Blum and N. Benvenisty, “The tumorigenicity of diploid and aneuploid human pluripotent stem cells,” Cell Cycle (Georgetown, Tex.), vol. 8, no. 23, pp. 3822–3830, 2009. View at Google Scholar
  23. T. E. Werbowetski-Ogilvie, M. Bossé, M. Stewart et al., “Characterization of human embryonic stem cells with features of neoplastic progression,” Nature Biotechnology, vol. 27, no. 1, pp. 91–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. U. Ben-David and N. Benvenisty, “The tumorigenicity of human embryonic and induced pluripotent stem cells,” Nature Reviews. Cancer, vol. 11, no. 4, pp. 268–277, 2011. View at Google Scholar
  25. K. Takahashi, K. Mitsui, and S. Yamanaka, “Role of ERas in promoting tumour-like properties in mouse embryonic stem cells,” Nature, vol. 423, no. 6939, pp. 541–545, 2003. View at Google Scholar
  26. B. Blum, O. Bar-Nur, T. Golan-Lev, and N. Benvenisty, “The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells,” Nature Biotechnology, vol. 27, no. 3, pp. 281–287, 2009. View at Google Scholar
  27. O. Hovatta, M. Jaconi, V. Töhönen et al., “A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes,” PLoS One, vol. 5, no. 4, article e10263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. C. Stevens, “Experimental production of testicular teratomas in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 52, pp. 654–661, 1964. View at Google Scholar
  29. L. J. Kleinsmith and G. B. Pierce, “Multipotentiality of single embryonal carcinoma cells,” Cancer Research, vol. 24, pp. 1544–1551, 1964. View at Google Scholar
  30. S. Strickland and V. Mahdavi, “The induction of differentiation in teratocarcinoma stem cells by retinoic acid,” Cell, vol. 15, no. 2, pp. 393–403, 1978. View at Google Scholar
  31. P. W. Andrews, “Human teratocarcinomas,” Biochimica et Biophysica Acta, vol. 948, no. 1, pp. 17–36, 1988. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Damjanov, “Teratocarcinoma: neoplastic lessons about normal embryogenesis,” The International Journal of Developmental Biology, vol. 37, no. 1, pp. 39–46, 1993. View at Google Scholar
  33. S. Sell and G. B. Pierce, “Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers,” Laboratory Investigation; a Journal of Technical Methods and Pathology, vol. 70, no. 1, pp. 6–22, 1994. View at Google Scholar
  34. P. W. Andrews, “From teratocarcinomas to embryonic stem cells,” Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 357, no. 1420, pp. 405–417, 2002. View at Google Scholar
  35. G. Caisander, H. Park, K. Frej et al., “Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture,” Chromosome Research: An International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology, vol. 14, no. 2, pp. 131–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Mayshar, U. Ben-David, N. Lavon et al., “Identification and classification of chromosomal aberrations in human induced pluripotent stem cells,” Cell Stem Cell, vol. 7, no. 4, pp. 521–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Gore, Z. Li, H. Fung et al., “Somatic coding mutations in human induced pluripotent stem cells,” Nature, vol. 471, no. 7336, pp. 63–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. L. C. Laurent, I. Ulitsky, I. Slavin et al., “Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture,” Cell Stem Cell, vol. 8, no. 1, pp. 106–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Tesarova, P. Simara, S. Stejskal, and I. Koutna, “The aberrant DNA methylation profile of human induced pluripotent stem cells is connected to the reprogramming process and is normalized during in vitro culture,” PLoS One, vol. 11, no. 6, article e0157974, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Simara, L. Tesarova, D. Rehakova et al., “DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing,” Stem Cell Research & Therapy, vol. 8, no. 1, p. 73, 2017. View at Publisher · View at Google Scholar
  41. F. Cheng, Q. Ke, F. Chen et al., “Protecting against wayward human induced pluripotent stem cells with a suicide gene,” Biomaterials, vol. 33, no. 11, pp. 3195–3204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Chen, B. Cai, Y. Gao et al., “Suicide gene-mediated ablation of tumor-initiating mouse pluripotent stem cells,” Biomaterials, vol. 34, no. 6, pp. 1701–1711, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Bedel, F. Beliveau, I. Lamrissi-Garcia et al., “Preventing pluripotent cell teratoma in regenerative medicine applied to hematology disorders,” Stem Cells Translational Medicine, vol. 6, no. 2, pp. 382–393, 2017. View at Google Scholar
  44. A. Bedel, F. Beliveau, I. Lamrissi-Garcia et al., “Preventing pluripotent cell teratoma in regenerative medicine applied to hematology disorders,” Stem Cells Translational Medicine, vol. 6, no. 2, pp. 382–393, 2017. View at Publisher · View at Google Scholar
  45. O. F. Gordeeva, “Antiproliferative and cytotoxic effects of different type cytostatics on mouse pluripotent stem and teratocarcinoma cells,” Ontogenez, vol. 43, no. 4, pp. 268–277, 2012. View at Google Scholar
  46. U. Ben-David, Q. Gan, T. Golan-Lev et al., “Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen,” Cell Stem Cell, vol. 12, no. 2, pp. 167–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lee, S. H. Moon, H. Jeong et al., “Inhibition of pluripotent stem cell-derived teratoma formation by small molecules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 35, pp. E3281–E3290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Zhang, Y. Pan, G. Qin et al., “Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium,” Cell Cycle (Georgetown, Tex.), vol. 13, no. 5, pp. 762–771, 2014. View at Google Scholar
  49. A. I. Spira and M. A. Carducci, “Differentiation therapy,” Current Opinion in Pharmacology, vol. 3, no. 4, pp. 338–343, 2003. View at Google Scholar
  50. S. Sell, “Stem cell origin of cancer and differentiation therapy,” Critical Reviews in Oncology/Hematology, vol. 51, no. 1, pp. 1–28, 2004. View at Google Scholar
  51. S. Sell, “Cancer stem cells and differentiation therapy,” Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 27, no. 2, pp. 59–70, 2006. View at Google Scholar
  52. Y. Toyooka, N. Tsunekawa, Y. Takahashi, Y. Matsui, M. Satoh, and T. Noce, “Expression and intracellular localization of mouse Vasa-homologue protein during germ cell development,” Mechanisms of Development, vol. 93, no. 1-2, pp. 139–149, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Toyooka, N. Tsunekawa, R. Akasu, and T. Noce, “Embryonic stem cells can form germ cells in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 20, pp. 11457–11462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. O. Lacham-Kaplan, “In vivo and in vitro differentiation of male germ cells in the mouse,” Reproduction (Cambridge, England), vol. 128, no. 2, pp. 147–152, 2004. View at Google Scholar
  55. C. Eguizabal, T. C. Shovlin, G. Durcova-Hills, A. Surani, and A. McLaren, “Generation of primordial germ cells from pluripotent stem cells,” Differentiation; Research in Biological Diversity, vol. 78, no. 2-3, pp. 116–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. O. F. Gordeeva, N. V. Lifantseva, and S. V. Khaĭdukov, “Expression patterns of germ line specific genes in mouse and human pluripotent stem cells are associated with regulation of ground and primed state of pluripotency,” Ontogenez, vol. 42, no. 6, pp. 403–424, 2011. View at Google Scholar
  57. J. L. Resnick, L. S. Bixler, L. Cheng, and P. J. Donovan, “Long-term proliferation of mouse primordial germ cells in culture,” Nature, vol. 359, no. 6395, pp. 550-551, 1992. View at Google Scholar
  58. G. Durcova-Hills, F. Wianny, J. Merriman, M. Zernicka-Goetz, and A. McLaren, “Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro,” Differentiation; Research in Biological Diversity, vol. 71, no. 2, pp. 135–141, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. L. V. Sharova, A. A. Sharov, Y. Piao et al., “Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains,” Developmental Biology, vol. 307, no. 2, pp. 446–459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Oliveros-Etter, Z. Li, K. Nee et al., “PGC reversion to pluripotency involves erasure of DNA methylation from imprinting control centers followed by locus-specific re-methylation,” Stem Cell Reports, vol. 5, no. 3, pp. 337–349, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Clifford, H. Chiba, D. Sobieszczuk, D. Metzger, and P. Chambon, “RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids,” The EMBO Journal, vol. 15, no. 16, pp. 4142–4155, 1996. View at Google Scholar
  62. J. Pacherník, V. Bryja, M. Esner, L. Kubala, P. Dvorák, and A. Hampl, “Neural differentiation of pluripotent mouse embryonal carcinoma cells by retinoic acid: inhibitory effect of serum,” Physiological Research/Academia Scientiarum Bohemoslovaca, vol. 54, no. 1, pp. 115–122, 2005. View at Google Scholar
  63. D. R. Soprano, B. W. Teets, and K. J. Soprano, “Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells,” Vitamins and Hormones, vol. 75, pp. 69–95, 2007. View at Google Scholar
  64. D. Su and L. J. Gudas, “Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells,” Biochemical Pharmacology, vol. 75, no. 5, pp. 1129–1160, 2008. View at Google Scholar
  65. L. Delacroix, E. Moutier, G. Altobelli et al., “Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells,” Molecular and Cellular Biology, vol. 30, no. 1, pp. 231–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. B. S. Pickens, B. W. Teets, K. J. Soprano, and D. R. Soprano, “Role of COUP-TFI during retinoic acid-induced differentiation of P19 cells to endodermal cells,” Journal of Cellular Physiology, vol. 228, no. 4, pp. 791–800, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. G. M. Kelly and M. I. Gatie, “Mechanisms regulating stemness and differentiation in embryonal carcinoma cells,” Stem Cells International, vol. 2017, Article ID 3684178, 20 pages, 2017. View at Publisher · View at Google Scholar
  68. T. Watabe and K. Miyazono, “Roles of TGF-beta family signaling in stem cell renewal and differentiation,” Cell Research, vol. 19, no. 1, pp. 103–115, 2009. View at Google Scholar
  69. N. Oshimori and E. Fuchs, “The harmonies played by TGF-β in stem cell biology,” Cell Stem Cell, vol. 11, no. 6, pp. 751–764, 2012. View at Google Scholar
  70. T. A. Beyer, M. Narimatsu, A. Weiss, L. David, and J. L. Wrana, “The TGFβ superfamily in stem cell biology and early mammalian embryonic development,” Biochimica et Biophysica Acta, vol. 1830, no. 2, pp. 2268–2279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Vallier, M. Alexander, and R. A. Pedersen, “Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells,” Journal of Cell Science, vol. 118, Part 19, pp. 4495–4509, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Greber, H. Lehrach, and J. Adjaye, “Control of early fate decisions in human ES cells by distinct states of TGFβ pathway activity,” Stem Cells and Development, vol. 17, no. 6, pp. 1065–1077, 2008. View at Google Scholar
  73. L. Vallier, T. Touboul, Z. Chng et al., “Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways,” PLoS One, vol. 4, no. 6, article e6082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. M. C. Nostro, F. Sarangi, S. Ogawa et al., “Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells,” Development (Cambridge, England), vol. 138, no. 5, pp. 861–871, 2011. View at Google Scholar
  75. P. W. Burridge, G. Keller, J. D. Gold, and J. C. Wu, “Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming,” Cell Stem Cell, vol. 10, no. 1, pp. 16–28, 2012. View at Google Scholar
  76. M. Bertacchi, G. Lupo, L. Pandolfini et al., “Activin/Nodal signaling supports retinal progenitor specification in a narrow time window during pluripotent stem cell neuralization,” Stem Cell Reports, vol. 5, no. 4, pp. 532–545, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. C. E. Weidgang, T. Seufferlein, A. Kleger, and M. Mueller, “Pluripotency factors on their lineage move,” Stem Cells International, vol. 2016, Article ID 6838253, 16 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Cho, S. Kim, H. Jeong et al., “Repair of ischemic injury by pluripotent stem cell based cell therapy without teratoma through selective photosensitivity,” Stem Cell Reports, vol. 5, no. 6, pp. 1067–1080, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Yagyu, V. Hoyos, F. D. Bufalo, and M. K. Brenner, “An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells,” Molecular Therapy: The Journal of the American Society of Gene Therapy, vol. 23, no. 9, pp. 1475–1485, 2015. View at Publisher · View at Google Scholar · View at Scopus